Gynecologic Cancer

So far in 2023, there has been an overwhelming shortage of chemotherapy drugs, of which several specifically impact gynecologic oncology providers and patients.

When I graduated from oncology fellowship in 2015, I went straight into an academic position thinking that I would continue to pursue my goals of early drug development and phase 1 clinical trials.

Cancer Moonshot’s goal of reducing the cancer death rate by at least 50% over the next 25 years will depend upon greater access to and utilization of cancer prevention interventions, according to a study presented at an NCI press briefing.

A quality improvement model successfully identified, educated and treated newly diagnosed women with gynecologic cancer at high risk for venous thromboembolism, according to study results.

The Healio Editors compiled a list of recent news from the Society of Gynecologic Oncology Annual Meeting held from March 25-28, 2023.

A cloud-based chatbot considerably improved identification of high-risk pathogenic variants in cancer genes, according to study results.

A digital tool that tracks patient-reported symptoms helped identify post-discharge complications among women with gynecologic cancer who underwent debulking surgery, according to retrospective study results.

Niraparib did not significantly extend OS among women with recurrent ovarian cancer, according to long-term follow-up results of the ENGOT-OV16/NOVA trial presented at Society of Gynecologic Oncology Annual Meeting on Women’s Cancer.

Women who underwent surgery for gynecologic cancers experienced decreased symptoms of anxiety and pain with the use of acupressure before surgery and acupuncture during surgery, according to study results published in Cancer.

Several novel treatment regimens for gynecologic cancer emerged during the past year.